Recruiting studies: Inherited Bmf Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
Phase 2 · 1 location(s) · Mitchell Cairo · NCT04099966 Natural History of Acquired and Inherited Bone Marrow Failure Syndromes
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT05012111 Experience and Management of Cancer Screening-Related Anxiety in Fanconi Anemia
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT06744283 Quercetin Dyskeratosis Congenita (DC)/Telomere Biology Disorders (TBD)
Phase 1 · 1 location(s) · Children's Hospital Medical Center, Cincinnati · NCT07628972 Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes
Phase N/A · 1 location(s) · Sohag University · NCT05436587 Mobilization of CD34+ Peripheral Blood Stem Cells in Patients With Diamond Blackfan Anemia Syndrome (DBAS)
Phase N/A · 1 location(s) · Northwell Health · NCT07186179 HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Phase 2 · 3 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02143830 Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
NA · 3 location(s) · Mayo Clinic · NCT02958462 Nucleoside Therapy in Patients With Telomere Biology Disorders
Phase 1 · 1 location(s) · Suneet Agarwal · NCT06817590 A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combine
Phase 2 · 2 location(s) · Franziska Wachter · NCT05796570 Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders
Phase 2 · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT03579875 Familial Investigations of Childhood Cancer Predisposition
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT03050268 French National Registry of Bone Marrow Failures
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT04781790 Role of Acetaldehyde in the Development of Oral Cancer
NA · 1 location(s) · Masonic Cancer Center, University of Minnesota · NCT05973656 Cancer in Inherited Bone Marrow Failure Syndromes
Phase N/A · 2 location(s) · National Cancer Institute (NCI) · NCT00027274 Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
Phase N/A · 1 location(s) · Paul Szabolcs · NCT04528355 Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT
Phase 1/Phase 2 · 1 location(s) · Children's Hospital of Philadelphia · NCT06839456 FANCA Gene Transfer for Fanconi Anemia Using a High-safety, High-efficiency, Self-inactivating Lentiviral Vector
NA · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03351868 T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
Phase 1/Phase 2 · 1 location(s) · Paul Szabolcs · NCT03653338 MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients
Phase N/A · 1 location(s) · University of Minnesota · NCT07649031 Assessing the Safety, Tolerability, and Efficacy of APR-2020 in Pediatric and Adolescent Subjects With RPS19 Deficient D
Phase 1 · 2 location(s) · Apriligen, Inc. · NCT07476183 Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
Phase N/A · 1 location(s) · Shwachman-Diamond Syndrome Alliance Inc · NCT06999954 A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropeni
Phase 3 · 114 location(s) · X4 Pharmaceuticals · NCT06056297 Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failu
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT04232085 Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study)
Phase N/A · 1 location(s) · Peter MacCallum Cancer Centre, Australia · NCT05196789 Shwachman Diamond Syndrome Registry and Study
Phase N/A · 4 location(s) · Boston Children's Hospital · NCT06056908 Imatinib to Increase RUNX1 Activity in Participants With Germline RUNX1 Deficiency
Phase 1 · 1 location(s) · National Cancer Institute (NCI) · NCT06090669 Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
Phase 2 · 1 location(s) · Paul Szabolcs · NCT01962415 Defining the Natural History of Squamous Cell Carcinoma in Fanconi Anemia
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT05687149 Investigation of the Genetics of Hematologic Diseases
Phase N/A · 1 location(s) · St. Jude Children's Research Hospital · NCT02720679

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.